107 related articles for article (PubMed ID: 17169375)
41. CD95-mediated apoptosis and DNA fragmentation in MS.
Heesen C; Georghiu S; Gbadamosi J; Schoser BG
Acta Neurol Scand; 2000 Nov; 102(5):333-6. PubMed ID: 11083512
[TBL] [Abstract][Full Text] [Related]
42. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
Lolli F; Mazzanti B; Pazzagli M; Peroni E; Alcaro MC; Sabatino G; Lanzillo R; Brescia Morra V; Santoro L; Gasperini C; Galgani S; D'Elios MM; Zipoli V; Sotgiu S; Pugliatti M; Rovero P; Chelli M; Papini AM
J Neuroimmunol; 2005 Oct; 167(1-2):131-7. PubMed ID: 16051375
[TBL] [Abstract][Full Text] [Related]
43. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
Rentzos M; Nikolaou C; Rombos A; Evangelopoulos ME; Kararizou E; Koutsis G; Zoga M; Dimitrakopoulos A; Tsoutsou A; Sfangos C
Clin Neurol Neurosurg; 2008 Dec; 110(10):992-6. PubMed ID: 18657352
[TBL] [Abstract][Full Text] [Related]
44. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Caniatti ML; Baldi E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2007 Dec; 192(1-2):219-25. PubMed ID: 17997167
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C.
Zaki Mel S; Auf FA; Ghawalby NA; Saddal NM
Immunol Invest; 2008; 37(2):163-70. PubMed ID: 18300041
[TBL] [Abstract][Full Text] [Related]
46. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Trabattoni D; Saresella M; Pacei M; Marventano I; Mendozzi L; Rovaris M; Caputo D; Borelli M; Clerici M
J Immunol; 2009 Oct; 183(8):4984-93. PubMed ID: 19794071
[TBL] [Abstract][Full Text] [Related]
47. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
[TBL] [Abstract][Full Text] [Related]
48. Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis.
Bagnato F; Durastanti V; Finamore L; Volante G; Millefiorini E
Neurol Sci; 2003 Dec; 24 Suppl 5():S301-4. PubMed ID: 14652795
[TBL] [Abstract][Full Text] [Related]
49. Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS.
Julià E; Edo MC; Horga A; Montalban X; Comabella M
Clin Immunol; 2009 Dec; 133(3):364-74. PubMed ID: 19740704
[TBL] [Abstract][Full Text] [Related]
50. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
Desplat-Jégo S; Feuillet L; Creidy R; Malikova I; Rance R; Khrestchatisky M; Hahm K; Burkly LC; Pelletier J; Boucraut J
J Leukoc Biol; 2009 Jan; 85(1):132-5. PubMed ID: 18945822
[TBL] [Abstract][Full Text] [Related]
51. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
Bar-Or A; Vollmer T; Antel J; Arnold DL; Bodner CA; Campagnolo D; Gianettoni J; Jalili F; Kachuck N; Lapierre Y; Niino M; Oger J; Price M; Rhodes S; Robinson WH; Shi FD; Utz PJ; Valone F; Weiner L; Steinman L; Garren H
Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
[TBL] [Abstract][Full Text] [Related]
52. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
[TBL] [Abstract][Full Text] [Related]
53. [Serum levels of interleukin-6 and interleukin-10 in patients with multiple sclerosis during intravenous immunoglobulin infusion].
Kazibutowska Z; Motta E; Huć M; Strzała-Orzeł M; Woźnik G
Wiad Lek; 2006; 59(9-10):626-9. PubMed ID: 17338118
[TBL] [Abstract][Full Text] [Related]
54. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
[TBL] [Abstract][Full Text] [Related]
55. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
Chang-Lin WU; Jian-Cheng XU; Fang LI; Hong XI; Xue-Min ZH; Qun CH; Xue-Wen LV
Int J Lab Hematol; 2007 Jun; 29(3):177-84. PubMed ID: 17474894
[TBL] [Abstract][Full Text] [Related]
56. Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.
Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
[TBL] [Abstract][Full Text] [Related]
57. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
58. Impaired CD95-mediated apoptosis in autoimmunity and occurrence of a p22 Caspase-8 cleavage product in JIA.
Feyen O; Telieps T; Schmitz I; Niehues T
Klin Padiatr; 2008; 220(6):358-64. PubMed ID: 18949671
[TBL] [Abstract][Full Text] [Related]
59. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
[TBL] [Abstract][Full Text] [Related]
60. Helminth infections associated with multiple sclerosis induce regulatory B cells.
Correale J; Farez M; Razzitte G
Ann Neurol; 2008 Aug; 64(2):187-99. PubMed ID: 18655096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
